Tuberculosis
T-SPOT®.
TB
Economic Impact
Guidelines
The Learning Zone
Healthcare FAQs
About Tuberculosis
Active TB Disease and Latent TB Infection
Diagnosing Tuberculosis
Why Choose T-SPOT®.
TB
TB Vaccination & Treatment
Patient Groups
Patient FAQs
Media Requests
Oxford Immunotec Announces that the Centers for Medicare and Medicaid Services (CMS) Increases Reimbursement for the T-SPOT
®
.
TB
Test CPT® Code 86481
Federal Supply Schedule (FSS) Contract Awarded to Oxford Diagnostic Laboratories for T-SPOT
®
.
TB
Testing
Study Results Show Switching from the Tuberculin Skin Test (TST) to an Interferon Gamma Release Assay (IGRA) can Improve Healthcare Worker Test Adherence at a Lower Cost
T-SPOT®.
TB
Detecting TB infection with unequalled clinical performance.
Follow us
Get Email Updates